C3.AI INC-A (724.DE) Fundamental Analysis & Valuation

FRA:724 • US12468P1049

Current stock price

7.428 EUR
+0.1 (+1.41%)
Last:

This 724.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. 724.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 724 has reported negative net income.
  • In the past year 724 has reported a negative cash flow from operations.
  • 724 had negative earnings in each of the past 5 years.
  • 724 had a negative operating cash flow in each of the past 5 years.
724.DE Yearly Net Income VS EBIT VS OCF VS FCF724.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • 724 has a Return On Assets of -48.51%. This is amonst the worse of the industry: 724 underperforms 89.81% of its industry peers.
  • The Return On Equity of 724 (-60.39%) is worse than 84.26% of its industry peers.
Industry RankSector Rank
ROA -48.51%
ROE -60.39%
ROIC N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
724.DE Yearly ROA, ROE, ROIC724.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • 724 has a Gross Margin of 43.45%. This is in the lower half of the industry: 724 underperforms 71.30% of its industry peers.
  • 724's Gross Margin has declined in the last couple of years.
  • 724 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
724.DE Yearly Profit, Operating, Gross Margins724.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 724.DE Health Analysis

2.1 Basic Checks

  • 724 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 724 has more shares outstanding than it did 1 year ago.
  • 724 has more shares outstanding than it did 5 years ago.
  • 724 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
724.DE Yearly Shares Outstanding724.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
724.DE Yearly Total Debt VS Total Assets724.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • 724 has an Altman-Z score of 1.06. This is a bad value and indicates that 724 is not financially healthy and even has some risk of bankruptcy.
  • 724 has a Altman-Z score of 1.06. This is in the lower half of the industry: 724 underperforms 67.59% of its industry peers.
  • 724 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC11%
724.DE Yearly LT Debt VS Equity VS FCF724.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 6.58 indicates that 724 has no problem at all paying its short term obligations.
  • 724 has a better Current ratio (6.58) than 91.67% of its industry peers.
  • 724 has a Quick Ratio of 6.58. This indicates that 724 is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 6.58, 724 belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.58
Quick Ratio 6.58
724.DE Yearly Current Assets VS Current Liabilites724.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 724.DE Growth Analysis

3.1 Past

  • The earnings per share for 724 have decreased strongly by -247.06% in the last year.
  • 724 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.22%.
  • 724 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.95% yearly.
EPS 1Y (TTM)-247.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-16.22%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%-45.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.04% on average over the next years. This is a very strong growth
  • 724 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.07% yearly.
EPS Next Y-264.69%
EPS Next 2Y-46.5%
EPS Next 3Y-12.37%
EPS Next 5Y25.04%
Revenue Next Year-35.88%
Revenue Next 2Y-23.88%
Revenue Next 3Y-13.49%
Revenue Next 5Y34.07%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
724.DE Yearly Revenue VS Estimates724.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
724.DE Yearly EPS VS Estimates724.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. 724.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 724. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 724. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
724.DE Price Earnings VS Forward Price Earnings724.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
724.DE Per share data724.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • 724's earnings are expected to decrease with -12.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.5%
EPS Next 3Y-12.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 724.DE Dividend Analysis

5.1 Amount

  • 724 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

724.DE Fundamentals: All Metrics, Ratios and Statistics

C3.AI INC-A

FRA:724 (3/23/2026, 7:00:00 PM)

7.428

+0.1 (+1.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners59.68%
Inst Owner ChangeN/A
Ins Owners24.23%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)307.39M
Net Income(TTM)-434.50M
Analysts49.17
Price Target14.27 (92.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.4%
Min EPS beat(2)-34.47%
Max EPS beat(2)25.67%
EPS beat(4)2
Avg EPS beat(4)-17.03%
Min EPS beat(4)-82.01%
Max EPS beat(4)25.67%
EPS beat(8)6
Avg EPS beat(8)22.21%
EPS beat(12)10
Avg EPS beat(12)28.22%
EPS beat(16)14
Avg EPS beat(16)32.83%
Revenue beat(2)0
Avg Revenue beat(2)-16.81%
Min Revenue beat(2)-31.07%
Max Revenue beat(2)-2.54%
Revenue beat(4)0
Avg Revenue beat(4)-15.88%
Min Revenue beat(4)-31.07%
Max Revenue beat(4)-2.02%
Revenue beat(8)1
Avg Revenue beat(8)-8.52%
Revenue beat(12)1
Avg Revenue beat(12)-6.32%
Revenue beat(16)2
Avg Revenue beat(16)-5.06%
PT rev (1m)-3.52%
PT rev (3m)-4.03%
EPS NQ rev (1m)-28.77%
EPS NQ rev (3m)-29.74%
EPS NY rev (1m)-14.87%
EPS NY rev (3m)-10.87%
Revenue NQ rev (1m)-35.86%
Revenue NQ rev (3m)-35.94%
Revenue NY rev (1m)-16.71%
Revenue NY rev (3m)-17.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.07
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 1.74
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS1.82
BVpS4.27
TBVpS4.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.51%
ROE -60.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.45%
FCFM N/A
ROA(3y)-26.48%
ROA(5y)-20.1%
ROE(3y)-31.79%
ROE(5y)-24.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.75%
GM growth 5Y-4.23%
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.54%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.58
Quick Ratio 6.58
Altman-Z 1.06
F-Score2
WACC11%
ROIC/WACCN/A
Cap/Depr(3y)472.89%
Cap/Depr(5y)307.85%
Cap/Sales(3y)12.2%
Cap/Sales(5y)7.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y-264.69%
EPS Next 2Y-46.5%
EPS Next 3Y-12.37%
EPS Next 5Y25.04%
Revenue 1Y (TTM)-16.22%
Revenue growth 3Y15.45%
Revenue growth 5Y19.95%
Sales Q2Q%-45.72%
Revenue Next Year-35.88%
Revenue Next 2Y-23.88%
Revenue Next 3Y-13.49%
Revenue Next 5Y34.07%
EBIT growth 1Y-46.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-125.94%
EBIT Next 3Y-1.2%
EBIT Next 5YN/A
FCF growth 1Y-36.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.83%
OCF growth 3YN/A
OCF growth 5YN/A

C3.AI INC-A / 724.DE Fundamental Analysis FAQ

What is the fundamental rating for 724 stock?

ChartMill assigns a fundamental rating of 3 / 10 to 724.DE.


What is the valuation status for 724 stock?

ChartMill assigns a valuation rating of 0 / 10 to C3.AI INC-A (724.DE). This can be considered as Overvalued.


How profitable is C3.AI INC-A (724.DE) stock?

C3.AI INC-A (724.DE) has a profitability rating of 0 / 10.


What is the financial health of C3.AI INC-A (724.DE) stock?

The financial health rating of C3.AI INC-A (724.DE) is 7 / 10.


Can you provide the expected EPS growth for 724 stock?

The Earnings per Share (EPS) of C3.AI INC-A (724.DE) is expected to decline by -264.69% in the next year.